PKCβ Antibody [B15A17]

Catalog No.: F5049

Application: Reactivity: Human, Mouse, Rat

Lane 1: K562, Lane 2: Raji

当該製品は品切れ状态で、ごメールアドレスを教えていただければ、在庫があると、メールで顧客様に伝えます。

代表番号: 045-509-1970|電子メール：sales@selleck.co.jp

使用情報

Dilution
WB1:1000 IP1:50 FCM1:200

Application
WB, IP, FCM

Source
Rabbit Monoclonal Antibody

Reactivity
Human, Mouse, Rat

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW
80 kDa

Datasheet & SDS

生物学的記述

Specificity
PKCβ Antibody [B15A17] detects endogenous levels of total PKCβ protein.

Clone
B15A17

Synonym(s)
Protein kinase C beta type;PRKCB;PKCB;PRKCB1

Background
Protein kinase C β (PKCβ) is a conventional (classical) serine/threonine kinase isoform within the PKC family that is activated downstream of phospholipase C–coupled receptors and functions as a major node in diacylglycerol (DAG)‑ and Ca²⁺‑dependent signaling cascades controlling cell growth, survival, and differentiation. PKCβ is expressed as two closely related splice variants, PKCβI and PKCβII, which share nearly identical catalytic and regulatory domains but differ at their C‑terminal tails, leading to isoform‑specific localization and substrate preference. Upon activation by DAG, phosphatidylserine, and Ca²⁺, PKCβ translocates to membrane‑associated compartments where it phosphorylates a range of effectors, including MARCKS and other cytoskeletal regulators, and engages pathways linked to glucose transport, cytoskeletal reorganization, and inflammatory signaling. PKCβII is a key component of the B‑cell receptor (BCR) signaling axis, where it modulates B‑cell development, selection, and antibody output, and its overexpression can skew B‑cell subsets and elevate serum IgM. PKCβII is frequently implicated in promoting cell survival, epithelial–mesenchymal transition (EMT), and metastasis, partly through activation of NF‑κB and other pro‑survival transcriptional programs, and pharmacologic inhibition of PKCβ has been explored as a means to suppress tumor growth and chemoresistance in several solid‑tumor models.

Background

Protein kinase C β (PKCβ) is a conventional (classical) serine/threonine kinase isoform within the PKC family that is activated downstream of phospholipase C–coupled receptors and functions as a major node in diacylglycerol (DAG)‑ and Ca²⁺‑dependent signaling cascades controlling cell growth, survival, and differentiation. PKCβ is expressed as two closely related splice variants, PKCβI and PKCβII, which share nearly identical catalytic and regulatory domains but differ at their C‑terminal tails, leading to isoform‑specific localization and substrate preference. Upon activation by DAG, phosphatidylserine, and Ca²⁺, PKCβ translocates to membrane‑associated compartments where it phosphorylates a range of effectors, including MARCKS and other cytoskeletal regulators, and engages pathways linked to glucose transport, cytoskeletal reorganization, and inflammatory signaling. PKCβII is a key component of the B‑cell receptor (BCR) signaling axis, where it modulates B‑cell development, selection, and antibody output, and its overexpression can skew B‑cell subsets and elevate serum IgM. PKCβII is frequently implicated in promoting cell survival, epithelial–mesenchymal transition (EMT), and metastasis, partly through activation of NF‑κB and other pro‑survival transcriptional programs, and pharmacologic inhibition of PKCβ has been explored as a means to suppress tumor growth and chemoresistance in several solid‑tumor models.

References
[1] Lee SH, et al. Clin Lung Cancer. 2010 May;11(3):169-75. [2] Kawakami T, et al. The Journal of Biochemistry 132.5 (2002): 677-682.

PVDFメンブレン孔径参考表

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須

* 大学・企業名 大学・企業名を記入してください

* 名前 名前を記入してください

* 電子メール 電子メール・アドレスを記入してください 有効なメールアドレスを入力してください

電話番号

* 内容 お問い合わせ内容をご入力ください

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%